Shunsuke Kondo

Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma

Kei Hiraoka, M Miyamoto, Y Cho et al. · British Journal of Cancer · 2006 · 511 citations · Full text

Medicine, Oncology, Pathology +17

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 421 citations · Full text

Medicine, Oncology, Pharmacology +12

Nivolumab alone or in combination with cisplatin plus gemcitabine in Japanese patients with unresectable or recurrent biliary tract cancer: a non-randomised, multicentre, open-label, phase 1 study

Makoto Ueno, Masafumi Ikeda, Chigusa Morizane et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 332 citations

Medicine, Oncology, Chemotherapy +5

New lithium ion conductors based on Li2S-SiS2 system

Shunsuke Kondo, Kazunori Takada, Yasuharu Yamamura · Solid State Ionics · 1992 · 189 citations

Natural Sciences, Materials Engineering, Materials Science +14

Cisplatin and Etoposide as First-line Chemotherapy for Poorly Differentiated Neuroendocrine Carcinoma of the Hepatobiliary Tract and Pancreas

Satoru Iwasa, Chigusa Morizane, T. Okusaka et al. · Japanese Journal of Clinical Oncology · 2010 · 169 citations

Medicine, Oncology, Pharmacology +16